Swiss National Bank boosted its position in MAXIMUS, Inc. (NYSE:MMS) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 110,507 shares of the health services provider’s stock after purchasing an additional 2,500 shares during the period. Swiss National Bank owned about 0.17% of MAXIMUS worth $7,910,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in MMS. Steward Partners Investment Advisory LLC purchased a new position in MAXIMUS in the fourth quarter worth about $169,000. OLD National Bancorp IN purchased a new position in MAXIMUS in the third quarter worth about $246,000. Cubist Systematic Strategies LLC boosted its position in MAXIMUS by 16.0% in the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after purchasing an additional 546 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in MAXIMUS by 51.3% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,581 shares of the health services provider’s stock worth $256,000 after purchasing an additional 1,214 shares during the last quarter. Finally, Belpointe Asset Management LLC purchased a new position in MAXIMUS in the third quarter worth about $269,000. 96.76% of the stock is currently owned by institutional investors and hedge funds.
MMS has been the topic of several research reports. Canaccord Genuity reissued a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Tuesday, February 13th. Finally, Maxim Group reaffirmed a “hold” rating and set a $69.00 price objective (up from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. MAXIMUS has a consensus rating of “Hold” and an average target price of $66.60.
In other news, CEO Richard A. Montoni sold 30,000 shares of MAXIMUS stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.25, for a total transaction of $2,077,500.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Mark Andrekovich sold 5,000 shares of MAXIMUS stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $68.80, for a total value of $344,000.00. Following the transaction, the insider now directly owns 22,996 shares in the company, valued at $1,582,124.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 102,650 shares of company stock worth $7,034,142. Insiders own 3.10% of the company’s stock.
MAXIMUS, Inc. (NYSE:MMS) opened at $68.16 on Friday. MAXIMUS, Inc. has a 12-month low of $57.12 and a 12-month high of $72.71. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.57 and a current ratio of 2.57. The firm has a market capitalization of $4,426.71, a PE ratio of 20.29, a PEG ratio of 2.26 and a beta of 1.21.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.01. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%. The firm had revenue of $623.10 million for the quarter, compared to analysts’ expectations of $624.36 million. During the same period in the previous year, the firm earned $0.71 EPS. The business’s quarterly revenue was up 2.6% on a year-over-year basis. sell-side analysts predict that MAXIMUS, Inc. will post 3.44 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.045 per share. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.26%. MAXIMUS’s payout ratio is currently 5.36%.
TRADEMARK VIOLATION WARNING: This article was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/24/swiss-national-bank-increases-holdings-in-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.